CPT1 is associated with type 2 diabetes and insulin resistance.
New research presented at the 2015 Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) suggests that CPT1 may also play a role in the pathology of multiple sclerosis (MS) [REF].